HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution.

Francesco PesSimona OnaliCinzia BalestrieriGoffredo AngioniFrancesco OrtuPaola PianoBarca LuciaRosetta SciosciaElija PrincicAnna Chiara BolliriMichele CasaleAlessandra ColaMaria ContiLorenza PeddisGiancarlo SerraStefano VaccaMartina LoiEnrico UrruClaudia MurruLaura MattaStefano R Del Giacco Sergio BabudieriIvana MaidaLuchino Chessa

Published in: Expert review of anti-infective therapy (2022)

DAAs treatment resulted in high SVR12 rates, was well tolerated and Increased CD4+ and CD8+, especially in patients with low CD4+ cell count at baseline.

Keyphrases

hepatitis c virus
human immunodeficiency virus
end stage renal disease
newly diagnosed
ejection fraction
stem cells
combination therapy
hiv aids
peritoneal dialysis
bone marrow
mesenchymal stem cells
peripheral blood
patient reported outcomes